Research Analysts Issue Forecasts for SNDX FY2025 Earnings
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) – Analysts at HC Wainwright decreased their FY2025 earnings per share (EPS) estimates for shares of Syndax Pharmaceuticals in a research report issued on Tuesday, March 4th. HC Wainwright analyst E. White now forecasts that the company will post earnings of ($3.86) per share for the year, down […]
